Principal serological markers used for CD diagnosis are the tissue transglutaminase (tTG) antibody test and the IgA-endomysial antibody (EmA) test, while other tests such as antigliadin (AGA) or antireticulum (ARA) are no longer routinely performed [8]. This evidence concerns the gene TGM2 and Cowden disease.